Pathogenic Mechanisms of Port Wine Stain and Repository of Port Wine Stain Biopsy Samples

NCT ID: NCT02051101

Last Updated: 2022-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

19 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-23

Study Completion Date

2019-01-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the pathogenic mechanisms of Port Wine Stain, collect biopsy samples and blood samples to characterize exosomes and metabolites from Port Wine Stain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The researcher can detect the defects in nervous system innervation to cutaneous blood vessels contribute to the pathogenesis of Port Wine Stain . Unveiling the pathogenic mechanisms of PWS is crucial to the design of new therapeutic strategies and can use the results to improve current PWS therapeutic outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Port-Wine Stain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Port Wine Stain Birthmark

Biopsy sample from Port Wine Stain Birthmark

Group Type OTHER

Biopsy sample from Port Wine Stain Birthmark

Intervention Type OTHER

Biopsy sample from Port Wine Stain Birthmark

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biopsy sample from Port Wine Stain Birthmark

Biopsy sample from Port Wine Stain Birthmark

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female of all ages.
* Not pregnant.
* Has diagnosis of port wine stain on the arms, legs, chest, bac.
* Ability to understand and carry out subject instructions.
* Subject willing to have skin biopsies on port wine stain and normal skin areas.

Exclusion Criteria

* Pregnant women.
* Port Wine Stain on the face.
* History of skin cancer.
* Current participation in an investigational drug evaluation
* Concurrent use of known photosensitizing drugs.
Minimum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beckman Laser Institute University of California Irvine

OTHER

Sponsor Role collaborator

University of California, Irvine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Beckman Laser Institute and Medical Center

Wenbin Tan, Ph.D. Project Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John s Nelson, MD

Role: STUDY_DIRECTOR

Beckman Laser Institute, UCI

Winbin Tan, PhD

Role: PRINCIPAL_INVESTIGATOR

Beckman Laser Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beckman Laser Institute

Irvine, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20139396

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.